Read more

December 26, 2023
1 min read
Save

Top nephrology news in AKI

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Healio has compiled a list of its most-read news items regarding AKI in 2023.

Readers were most interested in the impact of brief dialysis for some patients with AKI, post-hospital discharge care, kidney disease progression, lithium therapy and more.

AKI requiring dialysis
Readers were most interested in the impact of brief dialysis for some patients with AKI, post-hospital discharge care, kidney disease progression, lithium therapy and more. Image: Adobe Stock.

Brief dialysis may be best approach for some patients with AKI

Brief dialysis may lead to better outcomes for patients with AKI on outpatient hemodialysis, according to recently published data from researchers at the University of California, San Francisco. Read more.

Study: Post-hospital discharge care falls short in Canada for patients with AKI

In the study, 21.2% of hospitalized patients with preexisting chronic kidney disease saw a nephrologist within 90 days post-discharge. Read more.

Kidney disease progression after 5 years may be linked with AKI

Kidney disease progression after 5 years may be strongly associated with AKI, according to the results of a U.K.-based parallel-group cohort study. Read more.

Lithium therapy may be linked with AKI, poor kidney outcomes vs. valproate

Use of lithium vs. valproate as a prophylactic treatment may be associated with adverse kidney outcomes, including AKI, according to recently published research. Read more.

Mitochondrial transplantation may slow, reverse kidney damage

Mitochondrial transplantation may be effective in mitigating or reversing kidney damage, according to study results from researchers at the Wake Forest University School of Medicine. Read more.